Mark Lewis's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Mark Lewis
President and CEO
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
13
Since Nov 2021
27
Active registrations
0
Dec 2024 Reports per month Nov 2026
Reported meetings
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Jocelyn Milburn · Director, Policy, Innovation, Science and Economic Development Canada (ISED)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Justine Frame · Special Assistant, Policy,, Health Canada (HC)
Jibril Hussein · Policy Analyst, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Maggie Chi · Member of Parliament
Justine Frame · Special Assistant, Policy,, Health Canada (HC)
Jibril Hussein · Policy Advisor, Health Canada (HC)
nora draper · Parliamentary Secretary Assistant;, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Justine Frame · Special Assistant, Policy,, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
Jocelyn Milburn · Director, Policy, Innovation, Science and Economic Development Canada (ISED)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Karim Bardeesy · MP
Miro Froehlich · Director of Policy, Privy Council Office (PCO)
Nasser Haidar · Senior Policy Advisor, Privy Council Office (PCO)
Galen Richardson · Senior Advisor, Stakeholder Relations, Privy Council Office (PCO)
and 14 more Show fewer
Peter M. Boehm · Senator, Senate of Canada
Martin Moen · Associate Assistant Deputy, Global Affairs Canada (GAC)
Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
Annahat Kochhar · Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Hosai Zurmati Halim · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Chase Knight · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
victoria morton · Senior Communications Advisor,, House of Commons
Greg Orencsak · Deputy Minister, Health Canada (HC)
sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Justine Frame · Special Assistant, Policy,, Health Canada (HC)
Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
Official report
Shadad Khallidi · Deputy director of policy, Health Canada (HC)
Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
Official report
Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Executive Director, Innovation, Science and Economic Development Canada (ISED)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Manuela Tomic · Senior policy advisor, Innovation, Science and Economic Development Canada (ISED)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
luke carter · Manager, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Mike Poitras · Director, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Daniel MacDonald · Director General, Drugs for Rare Diseases, Health Canada (HC)
Luke Carter · Executive Director, Health Canada (HC)
Russell Vallee · Manager, Health Canada (HC)
Mike Poitras · Director, Health Canada (HC)
and 1 more Show fewer
elisha hurlock · Manager, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Max Lee · Senior Communications Advisor, Health Canada (HC)
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Kim Pate · Senator, Senate of Canada
Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
Official report
Marcus Powlowski · Member of Parliament
Health
Official report
william fassett · Office Manager, House of Commons
Simon Wood · Legislative Assistant, House of Commons
Health
Official report
Sean Casey · Member of Parliament
Robert Kitchen · Member of Parlilament, House of Commons
Health
Official report
Jade Mallette · Director of Parliamentary Affairs, House of Commons
Health
Official report
Daniel MacDonald · Director General, Drugs for Rare Diseases, Health Canada (HC)
Health
Official report
Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
Health
Official report
Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
Health
Official report
Shawn Driscoll · Stakeholder Relations Advisor, House of Commons
Darren Hall · Office of Leader of Opposition, House of Commons
Health
Official report
Stephen Ellis · Member of Parliament, House of Commons
Michelle Boudreau · Executive Director, Office of Pharmaceutical Management Strategies, Health Canada (HC)
Health
Official report
Allison Haley · Director of Parliamentary Affairs, House of Commons
Health
Official report
Helen Gao · Director of Policy, Indigenous Services Canada (ISC)
Michelle Mujoomdar · Director, Specialty Pharmaceuticals, Health Canada (HC)
Health
Official report
Page 1
Older →
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.